Fuse Oncology and Associated Medical Professionals of NY Introduces an End-to-End Radiation Oncology Workflow Proof of Concept in Urology

September 2026, Fuse Oncology and Associated Medical Professionals of NY have started a proof of concept for FuseRx at AMP’s radiation oncology center in Syracuse, New York. This project target to see how a digital workflow can help support prostate cancer care from the first radiation consultation through treatment. The goal is for physicians, physicists, dosimetrists, therapists, and nurses to work together in a more connected way.

It starts with the physician consultation and treatment-intent process, and will later include more members of the radiation oncology team. This partnership is meant to improve coordination between urology and radiation oncology and create a smoother process for patients receiving radiation treatment. Additionally, FuseRx is built to work with well-developed electronic medical records and oncology information systems.

Impact on the Radiation Therapy Sector

The global radiation therapy market size was calculated at USD 8.15 billion in 2025 and is predicted to increase from USD 8.64 billion in 2026 to approximately USD 19.29 billion by 2035, expanding at a CAGR of 9% from 2026 to 2035.

According to Precedence Research, radiation therapy typically involves several specialists; delays can occur when information moves between different systems and teams. This project aims to improve operations in radiation oncology practices. Its long-term value will ultimately depend on how well it functions in real-world situations by cut down on repetitive paperwork and maintaining patient safety.

A connected workflow would make it easier to arrange treatment plans and ensure communication.  The findings could affect how practices choose workflow technology, especially when many team members need access to the same treatment information.

Impact on the Healthcare IT Sector

The global healthcare IT market size accounted for USD 1,019.96 billion in 2026 and is predicted to be worth around USD 3,715.34 billion by 2035, growing at a CAGR of 15.48% from 2026 to 2035.

According to Precedence Research, many healthcare organizations rely on several systems for records, treatment planning, scheduling, and other tasks. For healthcare IT, this news shows the need for software that works with the systems clinics already use. The FuseRx pilot is a chance to see how a workflow-focused platform works in a real urology and radiation oncology setting.

Connecting these systems without making providers switch platforms is important when choosing new technology.  If it improves coordination and is easy to use, similar solutions could interest other areas of healthcare where digital processes are often disconnected.

Impact on the Urology Devices Sector

The global urology devices market size is calculated at USD 45.3 billion in 2025 and is predicted to increase from USD 47.57 billion in 2026 to approximately USD 73.16 billion by 2035, expanding at a CAGR of 4.91% from 2026 to 2035.

According to Precedence Research, this report provides urology organizations expanding their oncology services with useful insights on adding radiation treatment to their current care models. This project is crucial in prostate cancer care, from diagnosis and treatment discussions to choosing and giving therapy.

 Bringing radiation oncology workflows closer to the urology setting could help clinical teams work together more smoothly.  Its final impact will depend on whether it improves coordination without adding extra technology or workflow challenges for healthcare professionals.

Expert Opinion

From a healthcare technology and clinical operations point of view, this announcement is testing the workflow in a real urology-based radiation oncology setting. This proof of concept is a chance to gather real evidence about whether a unified workflow can make radiation oncology operations more coordinated and consistent by meeting clinicians and patients' requirements.

The value of an integrated platform depends on how well it fits into daily clinical practice, not just on how many features it has. Connecting treatment intent with the work of physicists, dosimetrists, and nurses could help close some communication gaps in complex radiation treatment. Additionally, this approach will work and require a focus on interoperability, usability, clinical safety, and staff adoption.